Melissa A Burns (Melissa Burns)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Factors

Top Venues

Pediatric blood & cancer

Dana-Farber/Children's Hospital Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana-Farber/Children's Hospital Cancer Center

United States

Instructor :: Pediatric Oncology

Publications

Wallace Bourgeois, Edward Yang, Roberto Chiarle, Melissa A Burns
Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T-lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia. Pediatric blood & cancer (2024)
Wallace Bourgeois, Edward Yang, Roberto Chiarle, Melissa A Burns
Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T-lymphoblastic lymphoma through lineage switch to CNS acute myeloid leukemia. Pediatric blood & cancer 71 (6) (2024)
Melissa A Burns, Andrew E Place, Kristen E Stevenson, Alejandro Gutiérrez, Suzanne Forrest, Yana Pikman, Lynda M Vrooman, Marian H Harris, Sarah K Hunt, Jane E O'Brien, Barbara L Asselin, Uma H Athale, Luis A Clavell, Peter D Cole, Lisa M Gennarini, Justine M Kahn, Kara M Kelly, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A Schorin, Maria-Luisa Sulis, Jennifer J G Welch, Donna S Neuberg, Stephen E Sallan, Lewis B Silverman
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001. Pediatric blood & cancer 68 (1) (2020)